Epócrates stock

Palm PALM, -5.21%, a maker of electronic handheld devices recently spun-off from 3Com COMS, +2.31%, will make EPocrates-branded units bundled with software designed to help doctors get medical and

The full year's average estimate for revenue is $109.9 million. The average EPS estimate is $0.19. Investor sentiment The stock has a three-star rating (out of five) at Motley Fool CAPS, with 36 Epocrates, Inc. (MM) stock quote and EPOC charts. Latest stock price today and the US's most active stock market forums. Epocrates, Inc. (MM) (EPOC) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Joining Epocrates can testify helpful as one can avail First Time Epocrates Coupons and discounts on all products. Epocrates offers flat 50% OFF discount on all orders for a limited period by using Epocrates Promo Codes. On part of items, Epocrates provides 50% OFF discount and customers can get from these selected ones to save money. Athenahealth Inc. ATHN, +0.00% agreed to acquire Epocrates Inc. EPOC for about $293 million in cash as the company looks for ways to share information among an expanded network of providers.

NEW YORK (AP) — Shares of health care technology company Epocrates Inc. rose to an annual high Monday after a Raymond James analyst upgraded the stock, praising the company for a change in strategy.

Epocrates reported revenues of $113.3 million in 2011, up 9% year over year. Stockholders at Epocrates (accounting for 17.5% of the company's outstanding common stock) have expressed that they are This statement on Schedule 13D relates to the voting common stock, par value $0.001 per share (the "Shares"), issued by Epocrates, Inc. ("Epocrates"). The address of the principal executive offices of Epocrates is 1100 Park Place, Suite 300, San Mateo, California 94403. Here's How Epocrates May Be Failing You Keep your eye on margins. The more Epocrates Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return. Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all

Joining Epocrates can testify helpful as one can avail First Time Epocrates Coupons and discounts on all products. Epocrates offers flat 50% OFF discount on all orders for a limited period by using Epocrates Promo Codes. On part of items, Epocrates provides 50% OFF discount and customers can get from these selected ones to save money.

Description. Developer of clinical information and decision support tools for health-care professionals. The company offers an integrated diagnostic suite, a drug reference guide, a guide to ICD-9 and CPT codes, a guide to various medical terms, and a free on-the-go learning center. 1 Wall Street analysts have issued 12-month price objectives for Materialise's stock. Their forecasts range from $16.25 to $20.00. On average, they anticipate Materialise's stock price to reach $18.13 in the next year. This suggests a possible upside of 16.2% from the stock's current price. View Analyst Price Targets for Materialise. Last year they acquired "Siemens Health Services" which came with 5,000 employees and a price tag of $1.39 billion. The stock price has performed quite well historically, though looking through the latest 10-Q it's tough to see just how much of their revenues are coming from EMR/EHR. Epocrates Reports 2011 Third Quarter Financial Results and Updated 2011 Guidance. SAN MATEO, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Epocrates, Inc. (Nasdaq:EPOC), a leading physician platform for clinical content, practice tools and health industry engagement, today reported financial results for its fiscal third quarter of 2011. Epocrates' revenue totaled $26.6 million in the third quarter

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 7, Epocrates Inc's Director, Peter C

More videos on YouTube. Share. Include playlist. An error occurred while retrieving sharing information. Please try again later. Watch later. Share  Company profile page for Epocrates LLC including stock price, company news, press releases, executives, board members, and contact information ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial. Get breaking news and analysis on Epocrates, Inc. (EPOC) stock, price quote and chart, trading and investing tools. Epocrates has a market cap of $293.2 million and is part of the health care sector and health services industry. Shares are up 33.2% year to date as of the close of trading on Monday. You can view

Moved Permanently. Redirecting to /

Epocrates, Inc. (NASDAQ: EPOC) is closer to its IPO. The company offers mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry. The terms have Epocrates stock jumped $2.14, or 22 percent, to $11.76 in premarket trading Monday. Epocrates makes an app that allows doctors to look up data about medications on smartphones and tablets. Drugmakers provide most of Epocrates' revenue by buying ads within the app. Epocrates Reports 2010 Fourth Quarter and Full-Year Financial Results and Provides 2011 Outlook. SAN MATEO, Calif., March 29, 2011 (GLOBE NEWSWIRE) -- Epocrates, Inc. (Nasdaq:EPOC), a leading provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry, today reported financial results for its fiscal fourth quarter and full-year of This is an all-cash offer for all outstanding shares of Epocrates' common stock, and athenahealth intends to finance this acquisition using available cash and funds available from its existing Epocrates Reports 2011 First Quarter Financial Results. SAN MATEO, Calif. - May 10, 2011 Epocrates, Inc. (NASDAQ: EPOC), a leading provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry, today reported financial results for its fiscal first quarter of 2011. Epocrates' net sales totaled $29.2 million in the first quarter of 2011 In connection with the closing of the Merger, Epocrates notified The NASDAQ Stock Market LLC ("NASDAQ") on March 12, 2013, that the Merger was consummated, and trading of the common stock of Epocrates on NASDAQ has been suspended.NASDAQ has filed a delisting application on Form 25 with the U.S. Securities and Exchange Commission (the "SEC") to report that the shares of Epocrates Epocrates Inc. (EPOC) is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties. NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities firm

More videos on YouTube. Share. Include playlist. An error occurred while retrieving sharing information. Please try again later. Watch later. Share  Company profile page for Epocrates LLC including stock price, company news, press releases, executives, board members, and contact information ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial. Get breaking news and analysis on Epocrates, Inc. (EPOC) stock, price quote and chart, trading and investing tools. Epocrates has a market cap of $293.2 million and is part of the health care sector and health services industry. Shares are up 33.2% year to date as of the close of trading on Monday. You can view